Effect of Ward-Based High-Flow Nasal Cannula (HFNC) Oxygen Therapy on Critical Care Utilization During the COVID-19 Pandemic: A Retrospective Cohort Analysis.
William K SilversteinJonathan S ZipurskyAndre C AmaralJerome A LeisLaura StrongJulie NardiAdina S WeinermanBrian M WongLynfa StroudPublished in: Journal of general internal medicine (2023)
With appropriate training and resources, treatment of COVID-19 patients with HFNC on GIM wards appears to be a feasible strategy to increase critical care capacity.